5 Andreas Halvorsen Adaptive Biotechnologies Trades
Andreas Halvorsen's position in Adaptive Biotechnologies is currently worth $391M. That's 1.09% of their equity portfolio (39th largest holding). The investor owns 19.46% of the outstanding Adaptive Biotechnologies stock. Andreas Halvorsen started to build up the position in Adaptive Biotechnologies in Q2 2019 and continued to invest until Q2 2019. Since then they sold 8.41M shares. The investor's estimated purchase price is $1.33B, resulting in a loss of 71%.
Avg closing price
Price range
Sold 3.2% shares (-1M shares)
Dec 14, 2020
Avg closing price
$57.18
Price range
$57.18
-
$57.18
Sold 7.5% shares (-2.5M shares)
Nov 11, 2020
Avg closing price
$51.93
Price range
$51.93
-
$51.93
Sold 12.8% shares (-4.91M shares)
Jan 28, 2020
Avg closing price
$31.09
Price range
$31.09
-
$31.09
Increased shares by 2595.2% (+37M shares)
Q2 2019
Avg closing price
$44.30
Price range
$40.30
-
$48.30
New holding (+1.43M shares)
Jun 26, 2019
Avg closing price
-
Price range
-
-
-
News about Adaptive Biotechnologies Corp and Andreas Halvorsen
Viking Global Investors reduced stake in Adaptive Biotechnologies Corp
https://www.investing.com/news/stock-market-news/viking-global-investors-reduced-stake-in-adaptive-biotechnologies-corp-2348133